Quote:
Originally posted by Florges
It charted since February, how is that bad?
|
23 weeks isn't horrible for a moderate hit (which NFY was), but it isn't great either. Plus, the fact that it's going recurrent after the minimum weeks required to be eligible for recurrency means it's not having great longevity.
A couple examples of recent hits of close to NFY's size that have had better longevity are Don't (34 weeks charting) and oui (27 weeks). oui was actually smaller than NFY; I think Don't is a better comparison.